Published in Virology on December 15, 1996
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci U S A (2000) 2.48
Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol (2004) 2.35
Epstein-barr virus-induced changes in B-lymphocyte gene expression. J Virol (2002) 1.72
Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J Virol (2003) 1.18
Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical. J Virol (2005) 1.08
EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J Virol (2003) 1.08
Multiple functions within the Epstein-Barr virus EBNA-3A protein. J Virol (1998) 1.05
EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes. Proc Natl Acad Sci U S A (2008) 1.01
Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth. Virology (2011) 0.98
MRPS18-2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties. Proc Natl Acad Sci U S A (2009) 0.95
Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation. J Virol (2001) 0.92
Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation. Adv Virus Res (2014) 0.86
Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes. J Virol (1999) 0.83
The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. PLoS Pathog (2015) 0.81
EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells. PLoS Pathog (2016) 0.79
Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis. Front Microbiol (2016) 0.76
Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C. Future Virol (2009) 0.75
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med (1992) 3.75
Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. J Clin Microbiol (1997) 3.46
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect Immun (1985) 2.88
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature (1988) 2.85
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci U S A (1999) 2.81
Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol (1988) 2.79
Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today (1991) 2.71
A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1996) 2.70
IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol (1999) 2.68
Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun (1999) 2.65
Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology (1994) 2.55
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med (1994) 2.47
T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity. Immunology (1986) 2.45
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J Exp Med (1990) 2.44
Monoclonal antibodies to a 28,000 mol. wt protein antigen of Mycobacterium leprae. Clin Exp Immunol (1985) 2.36
The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol (1992) 2.33
Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol (1989) 2.21
Generation and characterization of monoclonal antibodies to the phenolic glycolipid of Mycobacterium leprae. Infect Immun (1984) 2.20
A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science (1983) 2.18
Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol (2000) 2.17
Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J (1987) 2.09
Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate. Infect Immun (1988) 2.01
Comparison of Mycobacterium tuberculosis genomes reveals frequent deletions in a 20 kb variable region in clinical isolates. Yeast (2000) 1.96
Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71kD antigen, a member of the 70kD heat-shock protein family. Mol Microbiol (1989) 1.85
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. J Virol (1990) 1.79
Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J (1996) 1.74
Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens. Infect Immun (1987) 1.74
Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages. J Bacteriol (2000) 1.73
Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun (1987) 1.73
Three pathways for trehalose biosynthesis in mycobacteria. Microbiology (2000) 1.73
Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol (1998) 1.72
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun (1991) 1.69
Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade. J Biol Chem (1996) 1.68
Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol (2001) 1.66
A novel approach to the identification of T-cell epitopes in Mycobacterium tuberculosis using human T-lymphocyte clones. Immunology (1987) 1.63
Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med (2001) 1.61
New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol (1987) 1.58
Paleopathological and biomolecular study of tuberculosis in a medieval skeletal collection from England. Am J Phys Anthropol (2001) 1.56
Biochemical characterization of extracellular proteases from Vibrio cholerae. Infect Immun (1982) 1.54
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis (2006) 1.53
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
Partial purification of the Epstein-Barr virus nuclear antigen(s). J Biol Chem (1983) 1.44
Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun (2001) 1.44
Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J Immunol (2000) 1.41
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun (1997) 1.41
Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J Infect Dis (2000) 1.39
Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis. Microbiology (1999) 1.33
The identification of T cell epitopes in Mycobacterium tuberculosis using human T lymphocyte clones. Lepr Rev (1986) 1.32
Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J Virol (1984) 1.32
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells. Immunology (1991) 1.30
A gene from Mycobacterium tuberculosis which is homologous to the DnaJ heat shock protein of E. coli. Nucleic Acids Res (1988) 1.28
Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J Virol (1997) 1.28
Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J Virol (1996) 1.27
Structure of mycobacterial antigens. Br Med Bull (1988) 1.27
Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen. J Virol (1982) 1.25
A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents. Infect Immun (2000) 1.24
Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 1.24
Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol (1988) 1.23
Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur J Biochem (1997) 1.23
Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies. Proc Natl Acad Sci U S A (1991) 1.20
Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur J Immunol (1988) 1.18
p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem (1997) 1.18
The use of nitrocellulose immunoblots for the analysis of antigen recognition by T lymphocytes. J Immunol Methods (1988) 1.17
Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control. Trends Microbiol (1993) 1.17
Immune surveillance against Epstein-Barr virus. Semin Immunol (1992) 1.16
Cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite): a comparison of T- and B-cell antigen recognition. Immunology (1987) 1.15
Detection of mycobacterial lipids in skin biopsies from leprosy patients. Int J Lepr Other Mycobact Dis (1981) 1.14
The 19-kD antigen and protective immunity in a murine model of tuberculosis. Clin Exp Immunol (2000) 1.12
The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci (2014) 1.12
Stereoelectronic control in addition of nucleophiles to an amidinium ion. J Am Chem Soc (2001) 1.11
Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol (1994) 1.08
The influence of partial reinforcement on serial autoshaping with pigeons. Q J Exp Psychol B (1983) 1.07
Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene. Scand J Immunol (1999) 1.06
Induction of Epstein-Barr virus nuclear antigens. J Virol (1986) 1.06
Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood (1991) 1.04
Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol (1998) 1.03
Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy. J Infect Dis (1985) 1.03
Generation and characterization of monoclonal antibodies to 28-, 35-, and 65-kilodalton proteins of Mycobacterium tuberculosis. Infect Immun (1988) 0.99
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J Virol (1996) 0.99
Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot. J Gen Virol (1985) 0.99
Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis. Springer Semin Immunopathol (1991) 0.99
Genetic diversity among Mycobacterium bovis isolates: a preliminary study of strains from animal and human sources. J Clin Microbiol (2001) 0.98
Designing a vaccine for tuberculosis. BMJ (1996) 0.98
Effect of skin testing and segregation on the prevalence of bovine tuberculosis, and molecular typing of Mycobacterium bovis, in Ethiopia. Vet Rec (2007) 0.97
Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae. J Infect Dis (1984) 0.96
Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin. Vaccine (1999) 0.96
The mycobacterial GroEL stress protein: a common target of T-cell recognition in infection and autoimmunity. J Autoimmun (1989) 0.96
Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin Exp Immunol (2000) 0.95
Potassium inhibits free radical formation. Hypertension (1994) 0.95
Blueprint for the white plague. Nature (1998) 0.95
Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Cell Immunol (1991) 0.95
Comparison of polymerase chain reaction for IS6110 and Amplicor in the diagnosis of tuberculosis. Thorax (1996) 0.94
Heat shock proteins as virulence factors of pathogens. Curr Top Microbiol Immunol (1991) 0.94
Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology (1994) 0.93
The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes. Tuberculosis (Edinb) (2003) 0.93
The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth? Tissue Antigens (2007) 0.93
Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res Hum Retroviruses (1992) 0.93